|
|
Increasing the health equity and population-level impact of a digital therapeutic for smokers with psychiatric illness |
| 1K02DA054304-01A1 |
|
NIDA |
2022 |
|
|
Impact of Medicare Part D opioid safety policies on disabled beneficiaries before and during the COVID-19 pandemic |
| 1R01DA055131-01 |
|
NIDA |
2022 |
|
|
Improving MOUD Access, Opioid-Related Outcomes and Equity Among Medicare Beneficiaries with Disability |
| 1R01DA057568-01 |
|
NIDA |
2022 |
|
|
Effectiveness, toxicity and safety of opioid and benzodiazepine substitutes |
| 5R01DA039192-07 |
|
NIDA |
2022 |
|
|
The Opioid Crisis: The Effects and Unintended Consequences of State Policies on Opioid Analgesic Prescribing |
| 5R01DA045055-04 |
|
NIDA |
2022 |
|
|
Randomized Controlled Trial of a Novel Smoking Cessation Application Tailored to Individuals with Serious Mental Illness |
| 5R01DA047301-03 |
|
NIDA |
2022 |
|
|
Opioid/benzodiazepine polydrug abuse: Integrating research on mechanisms, treatment and policies |
| 5R33DA044946-04 |
|
NIDA |
2022 |
|
|
Testing an integrated bio-behavioral primary HIV prevention intervention among high-risk people who use drugs |
| 5 R01 DA044867-05 |
COPENHAVER, MICHAEL |
NIDA |
2021 |
|
|
Targeting the Cholinergic Pathway in HIV-associated Inflammation and Cognitive Dysfunction |
| 5 R01 DA044906-05 |
ASHARE, REBECCA |
NIDA |
2021 |
|
|
An Innovative Wearable Sensor For The Early Detection and Prevention Of Fatal Opioid Overdose |
| 5 R21 DA049566-02 |
IMPERATO-MCGINLEY, JULIANNE L |
NIDA |
2021 |
